Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Releases

267 Press Releases
DateTitleCompany
15 Mar 10 New Board Director Appointed Shire plc,
Published by
PR Newswire
04 Mar 10 District Court Upholds FDA's Grant of 5-Year Market Exclusivity to VYVANSE(R) Shire plc,
Published by
PR Newswire
01 Mar 10 Shire Supports Rare Disease Day 2010 Shire Pharmaceutical,
Published by
PR Newswire
27 Feb 10 Shire Announces FDA Approval of VPRIV(TM) (velaglucerase alfa for injection) for the Treatment of Type 1 Gaucher Disease Shire Pharmaceutical,
Published by
PR Newswire
26 Feb 10 Shire Provides Update on Biologics License Application (BLA) Filing for REPLAGAL(R) (agalsidase alfa) With the U.S. Food and Drug Administration (FDA) Shire Pharmaceutical,
Published by
PR Newswire
26 Feb 10 IPO Prospects High on the Agenda at BioTrinity Oxfordshire Bioscience Network (OBN),
Published by
PR Newswire
19 Feb 10 Excellent Results in a Transformational Year for Shire; Core Product Sales up 25% Shire Pharmaceutical,
Published by
PR Newswire
11 Feb 10 Shire Presents Positive Efficacy and Safety Data for velaglucerase alfa in Treatment of Naive Patients With Type 1 Gaucher Disease Shire Pharmaceutical,
Published by
PR Newswire
11 Feb 10 Shire Presents Positive Efficacy and Safety Data for velaglucerase alfa in Treatment of Naive Patients With Type 1 Gaucher Disease Shire plc,
Published by
PR Newswire
05 Feb 10 Full Year 2009 results date notification – 19 February 2010 Shire,
Published by
PharmiWeb.com
04 Feb 10 Shire Submits Biologics License Application (BLA) for REPLAGAL(R) With the U.S. Food and Drug Administration (FDA) Shire Plc,
Published by
PR Newswire
03 Feb 10 Shire to Present Important Study Findings for Gaucher Disease Treatment and GLD Development Program at the Lysosomal Disease Network (LDN) World Symposium Shire plc,
Published by
PR Newswire
02 Feb 10 VYVANSE® — new ADHD treatment option — now available in Canada Shire,
Published by
PharmiWeb.com
19 Jan 10 Directorate Change Shire,
Published by
PharmiWeb.com
02 Dec 09 Shire and Teva Settle Litigation Concerning Supply of ADDERALL XR Authorized Generic Shire Plc,
Published by
PR Newswire
24 Nov 09 Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease Shire Plc,
Published by
PR Newswire
11 Nov 09 Once-Daily INTUNIV™ (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide Shire,
Published by
PharmiWeb.com
06 Nov 09 New Shire Board Member Shire Plc,
Published by
PR Newswire
30 Oct 09 FDA Determines VYVANSE(R) was Properly Granted Five-Year Market Exclusivity Shire Plc,
Published by
PR Newswire
04 Nov 09 FDA Grants Priority Review for Shire's velaglucerase alfa for Type 1 Gaucher Disease Shire Plc,
Published by
PR Newswire
02 Sep 09 Elections for interim dividend in respect of the six months to June 30, 2009 Shire,
Published by
PharmiWeb.com
03 Sep 09 Shire Announces FDA Approval of Once-Daily INTUNIV™ (guanfacine) Extended Release Tablets for the Treatment of ADHD in Children and Adolescents Aged 6 to 17 Shire,
Published by
PharmiWeb.com
09 Sep 09 Update on velaglucerase alfa Shire,
Published by
PharmiWeb.com
08 Oct 09 Data from a head-to-head crossover study evaluating FOSRENOL® and sevelamer published today Shire,
Published by
PharmiWeb.com
26 Oct 09 FDA Determines VYVANSE® was Properly Granted Five-Year Market Exclusivity Shire,
Published by
PharmiWeb.com
28 Sep 09 Director/PDMR Shareholding Shire,
Published by
PharmiWeb.com
02 Sep 09 Total Voting Rights Shire,
Published by
PharmiWeb.com
21 Sep 09 Director/PDMR Shareholding Shire ,
Published by
PharmiWeb.com
02 Nov 09 Total Voting Rights Shire,
Published by
PharmiWeb.com
05 Nov 09 Shire Extends Agreement with Medidata Solutions for Trial Planning Products Shire,
Published by
PharmiWeb.com
Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.